SCHEMBL25818402

SCHEMBL25818402

Clc1nc(-c2cccc(-c3ccc4ccc(-c5ccc6ccc7ccccc7c6c5)cc4c3)c2)nc(-c2ccc3sc4ccccc4c3c2)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.33
CYP1B1 Q16678 3/20 0.32
CYP1A2 P05177 3/20 0.32
CYP1A1 P04798 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HSD17B1 P14061 2/20 0.32
HSD17B2 P37059 2/20 0.32
PIM3 Q86V86 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CYP17A1 P05093 1/20 0.31
CYP19A1 P11511 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
APP P05067 1/20 0.30
F9 P00740 1/20 0.30
NR1I3 Q14994 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818529 0.94 ALDH1A1 (0.34) GPR3CYP1B1CYP1A2CYP1A1HSD17B1
SCHEMBL22161533 0.94 HSD17B1 (0.37) GPR3CYP1A2KDM4EHSD17B1HSD17B2
SCHEMBL25818441 0.94 HSD17B1 (0.37) GPR3CYP1A2KDM4EHSD17B1HSD17B2
SCHEMBL25818528 0.93 PIM3 (0.38) GPR3CYP1A2KDM4EPIM3ALDH1A1
SCHEMBL22161491 0.89 GPR3 (0.39) GPR3CYP1A2KDM4EALDH1A1HSD17B10
SCHEMBL25818470 0.88 KDM4E (0.35) GPR3CYP1B1CYP1A2CYP1A1KDM4E
SCHEMBL25818453 0.88 ALDH1A1 (0.36) GPR3CYP1B1CYP1A2CYP1A1KDM4E
SCHEMBL24306957 0.88 HSD17B1 (0.38) GPR3CYP1B1CYP1A2CYP1A1KDM4E
SCHEMBL23437787 0.88 GPR3 (0.38) GPR3CYP1A2KDM4EPIM3ALDH1A1
SCHEMBL26363520 0.88 PIM3 (0.40) GPR3CYP1A2KDM4EPIM3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 GPR3 4847/4885CYP1B1 2831/4885CYP1A2 1608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.